Becton Dickinson Return on Tangible Equity 2010-2024 | BDX

Current and historical return on tangible equity values for Becton Dickinson (BDX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Becton Dickinson Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-06-30 $1.41B $-8.59B -15.14%
2024-03-31 $1.32B $-9.18B -13.63%
2023-12-31 $1.22B $-9.88B -12.10%
2023-09-30 $1.42B $-9.67B -13.67%
2023-06-30 $1.58B $-9.96B -14.49%
2023-03-31 $1.53B $-10.77B -13.86%
2022-12-31 $1.52B $-11.28B -13.47%
2022-09-30 $1.69B $-11.65B -14.56%
2022-06-30 $1.67B $-10.36B -13.96%
2022-03-31 $1.83B $-11.84B -14.62%
2021-12-31 $1.68B $-12.57B -13.30%
2021-09-30 $2.00B $-12.98B -15.86%
2021-06-30 $1.87B $-12.68B -14.57%
2021-03-31 $1.64B $-12.19B -12.58%
2020-12-31 $1.51B $-12.65B -10.62%
2020-09-30 $0.77B $-13.67B -5.02%
2020-06-30 $0.79B $-13.64B -4.87%
2020-03-31 $0.92B $-16.84B -5.40%
2019-12-31 $0.76B $-16.96B -4.38%
2019-09-30 $1.08B $-17.27B -6.12%
2019-06-30 $0.78B $-17.34B -4.33%
2019-03-31 $0.93B $-17.91B -5.02%
2018-12-31 $0.90B $-18.16B -4.75%
2018-09-30 $0.16B $-19.05B -0.82%
2018-06-30 $0.62B $-18.79B -4.23%
2018-03-31 $-0.10B $-19.34B 0.98%
2017-12-31 $0.29B $-20.13B -4.35%
2017-09-30 $1.03B $-0.51B -32.15%
2017-06-30 $0.76B $-0.91B -16.55%
2017-03-31 $1.32B $-5.48B -22.62%
2016-12-31 $1.31B $-5.91B -21.74%
2016-09-30 $0.98B $-6.07B -15.50%
2016-06-30 $1.14B $-5.80B -17.16%
2016-03-31 $0.81B $-6.31B -11.55%
2015-12-31 $0.69B $-7.02B -9.23%
2015-09-30 $0.70B $-7.40B -14.12%
2015-06-30 $0.82B $-7.34B -35.88%
2015-03-31 $1.08B $-8.06B 251.37%
2014-12-31 $1.15B $3.11B 34.99%
2014-09-30 $1.19B $3.20B 35.90%
2014-06-30 $0.97B $3.47B 29.74%
2014-03-31 $0.95B $3.37B 30.60%
2013-12-31 $0.94B $3.16B 32.18%
2013-09-30 $1.29B $3.10B 46.99%
2013-06-30 $1.49B $2.78B 58.77%
2013-03-31 $1.52B $2.63B 61.79%
2012-12-31 $1.53B $2.50B 62.30%
2012-09-30 $1.17B $2.25B 45.50%
2012-06-30 $1.18B $2.45B 42.65%
2012-03-31 $1.20B $2.64B 38.66%
2011-12-31 $1.22B $2.95B 36.65%
2011-09-30 $1.27B $3.04B 36.50%
2011-06-30 $1.37B $3.76B 36.43%
2011-03-31 $1.33B $3.55B 35.23%
2010-12-31 $1.32B $3.58B 34.24%
2010-09-30 $1.32B $4.13B 33.50%
2010-06-30 $1.24B $3.86B 31.50%
2010-03-31 $1.27B $3.82B 31.69%
2009-12-31 $1.24B $3.92B 30.82%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $69.388B $19.372B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.233B 19.03
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Cooper (COO) United States $20.668B 29.42
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
Merit Medical Systems (MMSI) United States $5.972B 30.50
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
CONMED (CNMD) United States $2.337B 19.50
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Lifevantage (LFVN) United States $0.175B 23.23
Pro-Dex (PDEX) United States $0.140B 27.95